SE7812283L - Sett att foroka rotavirus in vitro - Google Patents

Sett att foroka rotavirus in vitro

Info

Publication number
SE7812283L
SE7812283L SE7812283A SE7812283A SE7812283L SE 7812283 L SE7812283 L SE 7812283L SE 7812283 A SE7812283 A SE 7812283A SE 7812283 A SE7812283 A SE 7812283A SE 7812283 L SE7812283 L SE 7812283L
Authority
SE
Sweden
Prior art keywords
rotavirus
vitro
increase
way
increase rotavirus
Prior art date
Application number
SE7812283A
Other languages
English (en)
Other versions
SE445466B (sv
Inventor
J D Almeida
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7812283L publication Critical patent/SE7812283L/sv
Publication of SE445466B publication Critical patent/SE445466B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12361—Methods of inactivation or attenuation
    • C12N2720/12364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7812283A 1977-12-01 1978-11-29 Sett att foroka rotavirus in vitro SE445466B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5009477 1977-12-01
GB5390677 1977-12-24

Publications (2)

Publication Number Publication Date
SE7812283L true SE7812283L (sv) 1979-06-02
SE445466B SE445466B (sv) 1986-06-23

Family

ID=26266615

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7812283A SE445466B (sv) 1977-12-01 1978-11-29 Sett att foroka rotavirus in vitro

Country Status (10)

Country Link
US (1) US4205131A (sv)
JP (1) JPS5495789A (sv)
CH (1) CH646194A5 (sv)
DE (1) DE2851928A1 (sv)
DK (1) DK152516C (sv)
FI (1) FI63060C (sv)
FR (1) FR2410675A1 (sv)
GB (1) GB2009786A (sv)
NL (1) NL191183C (sv)
SE (1) SE445466B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33164E (en) * 1979-05-15 1990-02-13 Mobay Corporation Influenza vaccine production in liquid cell culture
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
US4624850A (en) * 1984-02-09 1986-11-25 Royal Children's Hospital Research Foundation Live attenuated human rotavirus vaccine
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5147639A (en) * 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
ATE429246T1 (de) * 1994-11-10 2009-05-15 Baxter Healthcare Sa Verfahren zur herstellung von biologischen produkten in protein-freiem kultur
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US6110724A (en) * 1996-10-18 2000-08-29 The Research Foundation For Microbial Diseases Of Osaka University Rotavirus antigen, vaccine and diagnostic agent for rotavirus infections, and a method for producing the antigen
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6656719B1 (en) * 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
FR2801900B1 (fr) * 1999-12-03 2004-02-27 Pasteur Merieux Serums Vacc Methode de production de cellules animales adherentes
US6830917B2 (en) 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
US20070190032A1 (en) * 2006-02-13 2007-08-16 Oncolytics Biotech Inc. Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy
GB2451216B (en) * 2006-05-12 2011-05-04 Bharat Biotech Int Ltd A stabilised vaccine composition comprising a viral antigen, HSA and a hydrolysed protein
CN117070475B (zh) * 2023-10-13 2023-12-29 金宇保灵生物药品有限公司 牛轮状病毒无血清悬浮培养方法及其产品和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1539221A (en) * 1976-09-30 1979-01-31 Wellcome Found Viral preparations

Also Published As

Publication number Publication date
DK542878A (da) 1979-06-02
FR2410675A1 (fr) 1979-06-29
NL191183B (nl) 1994-10-03
JPS6150599B2 (sv) 1986-11-05
DE2851928A1 (de) 1979-06-21
DK152516B (da) 1988-03-07
FI63060B (fi) 1982-12-31
FI63060C (fi) 1983-04-11
JPS5495789A (en) 1979-07-28
DE2851928C2 (sv) 1987-06-04
CH646194A5 (de) 1984-11-15
DK152516C (da) 1988-08-01
FR2410675B1 (sv) 1983-12-16
NL7811763A (nl) 1979-06-06
GB2009786A (en) 1979-06-20
US4205131A (en) 1980-05-27
FI783663A (fi) 1979-06-02
NL191183C (nl) 1995-03-01
SE445466B (sv) 1986-06-23

Similar Documents

Publication Publication Date Title
SE7805329L (sv) Sett att framstella n-alkylpiperidinderivat
SE7805276L (sv) Sett att framstella liposomblandningar
SE7812283L (sv) Sett att foroka rotavirus in vitro
SE7611646L (sv) Grundmassa och sett att framstella densamma
SE7806122L (sv) Kontaktlins och sett att framstella densamma
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7606280L (sv) Sett att framstella etrar
SE7801537L (sv) Sett att framstella pyrrolidinderivat
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE7902504L (sv) Sett att paverka vextlighet
SE7805022L (sv) Sett att framstella limningar
IT7851197A0 (it) Perfezionamenti alle lampade
SE430687B (sv) Sett att framstella hexanitrostilben
SE7900238L (sv) Sett att setta samman formar
SE7708841L (sv) Sett att framstella rifamycinforeningar
SE7806317L (sv) Sett att framstella koppar
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE7804126L (sv) Sett att framstella vulkanisat
SE425321B (sv) Sett att reducera vanadinoxider
SE410733B (sv) Sett att framstella vissa angivna oximetrar
SE7714506L (sv) Sett att framstella packningar
SE7810355L (sv) Sett att framstella sarkosinoxidas
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE7801030L (sv) Pentapeptidkompositioner och sett att framstella desamma

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7812283-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7812283-5

Format of ref document f/p: F